Relmada Therapeutics, Inc. RLMD Total debt
Discontinued — last reported Q2 '23
Total debt at other companies
Other financials
Where this comes from
Calculated from Relmada Therapeutics, Inc.’s reported figures.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed August 8, 2023, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s total debt?
- Relmada Therapeutics, Inc. (RLMD) reported total debt of $104.06M in Q2 2023.
- How has Relmada Therapeutics, Inc.'s total debt changed year-over-year?
- Relmada Therapeutics, Inc.'s total debt decreased by 40.4% year-over-year, from $174.69M to $104.06M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.